Answers are grounded in this paper and cite their sources.
Case report highlights hormonal management outcomes in monozygotic transgender male twins, suggesting genetic influences on gender identity.
Introduction Gender dysphoria is defined as a marked and persistent incongruence between an individual’s assigned gender at birth and their experienced or expressed gender identity. After psychiatric evaluation and follow-up, patients are referred to the Endocrinology clinic for hormonal management. Here, we present monozygotic transgender male twins followed up in our clinic. Clinical Case Monozygotic twins, 27-year-old individuals assigned female at birth, were referred to our endocrinology clinic by the psychiatry department in July 2024. They live with their mother in a central of Istanbul. Their parents divorced when they 6, and they have had no contact with their father since. Both completed developmental milestones (walking, speech) at expected ages. Twin 1 graduated with a degree in business administration, while Twin 2 completed high school. In childhood, both reported enjoying dressing like boys and playing with boys. They stated that they did not feel the need to discuss their gender identity with each other, because they both accepted themselves and each other as being in male bodies. Twin 1 recalled having a crush on a girl in the first grade. At their initial endocrinology visit, both patients reported regular menstrual cycles, with no significant hirsutism, alopecia, or androgenic symptoms. Neither had a history of chronic illness or regular medication use, but both smoked approximately half a pack of cigarettes daily. Both had 46,XX karyotypes. On physical examination; both twins had a history of mastectomy and their Ferriman–Gallwey score were: 6/7 Laboratory results showed (Twin 1/Twin 2): Prolactin: 10.1/21 ng/mL (4–20) 17-OH-Progesterone: 0.46/0.91 ng/mL (<2) FSH: 6/5.4 IU/L (3.5–12.5) LH: 5/5.6 IU/L (2.5–12.5) Estradiol: 32/86 ng/L (30–90) Total Testosterone: 25/31 ng/dL (8–48) TSH: 0.9/0.9 mIU/L (0.5–4.5) Hgb: 10.2/12.6 g/dL (12–16) MCV: 65.2/75.3 fL (80–100) Ferritin: 4/7 μg/L (13–50) WBC: 6,520/5,890 x10³/mm³ PLT: 314/295 x10³/mm³ Creatinine: 0.75/0.9 mg/dL (0.5–0.9) 25-OH VitaminD: 16.7/27 μg/L (30–100) Total Cholesterol: 151/153 mg/dL (<200) Glucose: 88/89 mg/dL (74–106) AST: 14/12 U/L (0–32) ALT: 10/7 U/L (0–33) Bone mineral density measurements were normal. Since February 2025, both patients have been on intramuscular testosterone 250 mg every 21 days. They are monitored every 3 months. During follow-up, increased skin oiliness, acneiform lesions, and facial/body hair were seen. Voice deepening and amenorrhea were observed. No mood-related adverse effects, such as anger or irritability were reported. Last testosterone levels were 555 and 725 ng/dL, on target. Conclusion Twin studies consistently demonstrate higher concordance among monozygotic twins compared to dizygotic twins, suggesting heritable mechanisms. While environmental and epigenetic factors are also known to play a role, familial studies have consistently indicated a strong association between genetic susceptibility and gender identity development.
No takes yet. Share an insight, caveat, or question.
Salva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: